Westerlund, Emil
Marelsson, Sigurður E
Ehinger, Johannes K
Sjövall, Fredrik
Morota, Saori
Åsander Frostner, Eleonor
Oldfors, Anders
Darin, Niklas
Lundgren, Johan
Hansson, Magnus J
Fellman, Vineta
Elmér, Eskil
Article History
Received: 3 May 2017
Accepted: 19 September 2017
First Online: 15 November 2017
Competing interests
: Drs Ehinger, Hansson, and Elmér and Åsander Frostner have equity interests in, and/or have received salary support from NeuroVive Pharmaceutical AB, a public company developing pharmaceuticals in the field of mitochondrial medicine. The other authors declare no financial or commercial conflict of interest.